Cano Health (NYSE:CANO) Reaches New 12-Month Low at $6.96

Cano Health, Inc. (NYSE:CANO) shares reached a new 52-week low during mid-day trading on Thursday . The company traded as low as $6.96 and last traded at $6.97, with a volume of 14187 shares traded. The stock had previously closed at $7.30.

CANO has been the subject of a number of recent research reports. Cowen reduced their price target on shares of Cano Health from $18.00 to $15.00 and set an “outperform” rating for the company in a research report on Tuesday, December 7th. Zacks Investment Research lowered shares of Cano Health from a “buy” rating to a “hold” rating in a research report on Tuesday. Citigroup initiated coverage on shares of Cano Health in a research report on Tuesday, September 21st. They set a “buy” rating and a $20.00 price target for the company. Jefferies Financial Group started coverage on shares of Cano Health in a research report on Wednesday, October 20th. They set a “buy” rating and a $17.00 price target for the company. Finally, Wolfe Research started coverage on shares of Cano Health in a report on Friday, October 1st. They set an “outperform” rating and a $19.00 target price for the company. Two analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat.com, Cano Health has an average rating of “Buy” and an average target price of $16.00.

The company has a debt-to-equity ratio of 1.07, a quick ratio of 3.32 and a current ratio of 3.33. The firm’s fifty day moving average price is $9.40 and its two-hundred day moving average price is $11.08.

Cano Health (NYSE:CANO) last posted its earnings results on Tuesday, November 9th. The company reported ($0.02) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.01). The firm had revenue of $526.80 million for the quarter, compared to analysts’ expectations of $455.61 million. As a group, sell-side analysts anticipate that Cano Health, Inc. will post 0.08 earnings per share for the current year.

In related news, CEO Marlow Hernandez purchased 15,000 shares of the company’s stock in a transaction that occurred on Monday, December 6th. The shares were purchased at an average price of $8.00 per share, with a total value of $120,000.00. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Solomon D. Trujillo bought 97,000 shares of the stock in a transaction on Thursday, November 18th. The shares were acquired at an average cost of $10.55 per share, for a total transaction of $1,023,350.00. The disclosure for this purchase can be found here. Insiders purchased a total of 132,500 shares of company stock worth $1,329,925 in the last three months.

A number of institutional investors and hedge funds have recently made changes to their positions in CANO. Wolverine Asset Management LLC boosted its stake in Cano Health by 398.7% during the 3rd quarter. Wolverine Asset Management LLC now owns 4,164 shares of the company’s stock worth $52,000 after purchasing an additional 3,329 shares during the last quarter. Dark Forest Capital Management LP acquired a new stake in Cano Health during the 3rd quarter worth $93,000. GSA Capital Partners LLP acquired a new stake in Cano Health during the 3rd quarter worth $135,000. Stifel Financial Corp acquired a new stake in Cano Health during the 2nd quarter worth $138,000. Finally, Bank of America Corp DE acquired a new stake in Cano Health during the 2nd quarter worth $139,000. 38.47% of the stock is currently owned by institutional investors.

Cano Health Company Profile (NYSE:CANO)

Cano Health, LLC owns and operates health care centers and pharmacies. It provides medical, dental, urgent care, an in-house laboratory, and specialty services. The company offers patient-centric programs, such as home visits, telehealth, transition of care, and high risk and complex care management.

Read More: Dual Listing What You Need to Know

Receive News & Ratings for Cano Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cano Health and related companies with MarketBeat.com's FREE daily email newsletter.